EE200300177A - m-aminofenüüliminoimidasolidiinderivaadid uriinipidamatuse raviks - Google Patents

m-aminofenüüliminoimidasolidiinderivaadid uriinipidamatuse raviks

Info

Publication number
EE200300177A
EE200300177A EEP200300177A EEP200300177A EE200300177A EE 200300177 A EE200300177 A EE 200300177A EE P200300177 A EEP200300177 A EE P200300177A EE P200300177 A EEP200300177 A EE P200300177A EE 200300177 A EE200300177 A EE 200300177A
Authority
EE
Estonia
Prior art keywords
aminophenyliminoimidazolidine
derivatives
treatment
urinary incontinence
incontinence
Prior art date
Application number
EEP200300177A
Other languages
English (en)
Inventor
Esser Franz
Arielle Jane-Josee Pouzet Pascale
Kitagawa Hisato
Sakai Kenji
Muramatsu Ikunobu
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of EE200300177A publication Critical patent/EE200300177A/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EEP200300177A 2000-10-14 2001-10-11 m-aminofenüüliminoimidasolidiinderivaadid uriinipidamatuse raviks EE200300177A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10051005 2000-10-14
PCT/EP2001/011764 WO2002032876A2 (de) 2000-10-14 2001-10-11 Neue m-amino-phenylimino-imidazolidin-derivate zur behandlung der harninkontinenz

Publications (1)

Publication Number Publication Date
EE200300177A true EE200300177A (et) 2003-08-15

Family

ID=7659815

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300177A EE200300177A (et) 2000-10-14 2001-10-11 m-aminofenüüliminoimidasolidiinderivaadid uriinipidamatuse raviks

Country Status (23)

Country Link
EP (1) EP1328517A2 (et)
JP (1) JP2004511547A (et)
KR (1) KR20030046503A (et)
CN (1) CN1471514A (et)
AR (1) AR035923A1 (et)
AU (1) AU2002215943A1 (et)
BG (1) BG107711A (et)
BR (1) BR0114603A (et)
CA (1) CA2425563A1 (et)
CZ (1) CZ20031333A3 (et)
DE (1) DE10150312A1 (et)
EA (1) EA200300460A1 (et)
EC (1) ECSP034517A (et)
EE (1) EE200300177A (et)
HU (1) HUP0302245A3 (et)
IL (1) IL155338A0 (et)
MX (1) MXPA03003162A (et)
NO (1) NO20031697L (et)
PL (1) PL361359A1 (et)
SK (1) SK4342003A3 (et)
WO (1) WO2002032876A2 (et)
YU (1) YU28203A (et)
ZA (1) ZA200302345B (et)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806811A1 (de) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz

Also Published As

Publication number Publication date
BR0114603A (pt) 2003-10-14
CZ20031333A3 (cs) 2003-08-13
DE10150312A1 (de) 2002-07-04
EA200300460A1 (ru) 2004-02-26
PL361359A1 (en) 2004-10-04
IL155338A0 (en) 2003-11-23
ECSP034517A (es) 2003-04-25
SK4342003A3 (en) 2003-10-07
EP1328517A2 (de) 2003-07-23
JP2004511547A (ja) 2004-04-15
WO2002032876A3 (de) 2002-07-18
CN1471514A (zh) 2004-01-28
MXPA03003162A (es) 2004-12-06
KR20030046503A (ko) 2003-06-12
NO20031697D0 (no) 2003-04-11
AU2002215943A1 (en) 2002-04-29
YU28203A (sh) 2006-05-25
HUP0302245A3 (en) 2004-01-28
AR035923A1 (es) 2004-07-28
HUP0302245A2 (hu) 2003-10-28
BG107711A (en) 2004-02-27
WO2002032876A2 (de) 2002-04-25
CA2425563A1 (en) 2002-04-25
NO20031697L (no) 2003-05-26
ZA200302345B (en) 2004-04-23

Similar Documents

Publication Publication Date Title
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
AU2001275257A1 (en) Methods and devices for the treatment of urinary incontinence
DE60029737D1 (de) Wegwerfwindel
NO20041833L (no) Heterocykliske forbindelser for anvendelse i behandlingen av forstyrrelser i urinveissystemet
IL158050A0 (en) Use of selective cox-2 inhibitors for the treatment of urinary incontinence
PT1413305E (pt) Derivados aril (ou heteroaril) azolilcabrinol para o tratamento de incontinencia urinaria
DE60105927D1 (de) Wegwerfwindel
DE60105232D1 (de) Wegwerfwindel
NO20030978L (no) Behandling av urindysfunksjon
AU2002233210A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
HUP0302430A3 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontience
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
NO20012569D0 (no) Anvendelse av aryl-substituerte syklobutylaminer for behandling av urininkontinens
HUP0303268A3 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
AU2002233209A1 (en) Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
AU2002223688A1 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
IL162776A0 (en) 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence
EE200300379A (et) Alküülfenüüliminoimidasolidiini derivaadid uriinipidamatuse ravimiseks
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
EE200300177A (et) m-aminofenüüliminoimidasolidiinderivaadid uriinipidamatuse raviks
NO20033428L (no) Anvendelse av 2-amino-1(4-hydroksy-3-metansulfonamidofenyl)- etanol for behandling av urin-inkontinens
DK1330255T3 (da) Præparat af cimicifuga til behandling af inkontinens
SI1413305T1 (sl) Aril (ali heteroaril) azolikarbonil derivati za zdravljenje urinske inkontinence
SI1353660T1 (sl) Uporaba substituiranih 6-dimetilaminometil-1-fenil-cikloheksanskih spojin za terapijo urinske inkontinence
FI20011540A0 (fi) Miesten kertakäyttöinen virtsainkontinenssisuoja

Legal Events

Date Code Title Description
HD1A Correction of address